ShockWave Medical, Inc. (SWAV): Price and Financial Metrics

ShockWave Medical, Inc. (SWAV): $329.00

1.48 (+0.45%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

SWAV Price/Volume Stats

Current price $329.00 52-week high $331.58
Prev. close $327.52 52-week low $157.00
Day low $327.39 Volume 1,302,700
Day high $329.80 Avg. volume 963,086
50-day MA $283.57 Dividend yield N/A
200-day MA $230.56 Market Cap 12.30B

SWAV Stock Price Chart Interactive Chart >


ShockWave Medical, Inc. (SWAV) Company Bio


Shockwave Medical, Inc. operates as a medical device company. It focuses on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The firm offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. The company was founded by Daniel Hawkins, John M. Adams, and Todd J. Brinton in 2009 and is headquartered in Santa Clara, CA.


SWAV Latest News Stream


Event/Time News Detail
Loading, please wait...

SWAV Latest Social Stream


Loading social stream, please wait...

View Full SWAV Social Stream

Latest SWAV News From Around the Web

Below are the latest news stories about SHOCKWAVE MEDICAL INC that investors may wish to consider to help them evaluate SWAV as an investment opportunity.

13 High Growth Healthcare Stocks to Buy

In this article, we will take a look at 13 high growth healthcare stocks to buy. To skip our analysis of the recent market activity, you can go directly to see the 5 Best High Growth Healthcare Stocks to Buy. For the purpose of this article, we have defined high growth stocks as stocks that […]

Yahoo | December 26, 2023

Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, announced today that the company will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, which is being held from Monday, January 8 to Thursday, January 11, 2024, in San Francisco, CA. Shockwave management is scheduled for a live presentation on Wednesday, Ja

Yahoo | December 20, 2023

Insider Sell Alert: President & CEO Douglas Godshall Sells 5,000 Shares of ShockWave ...

ShockWave Medical Inc (NASDAQ:SWAV) has recently witnessed a significant insider sell by its President &

Yahoo | December 19, 2023

What Makes Shockwave Medical (SWAV) a Potential Investment?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy outperformed the Russell Midcap Growth Index and returned -4.11% (net) while the index return was -5.22%. The third quarter saw a decline in […]

Yahoo | December 18, 2023

Reasons to Invest in Shockwave Medical (SWAV)

ClearBridge Investments, an investment management firm, released its third-quarter 2023 “Mid Cap Growth Strategy” investor letter, a copy of which can be downloaded here. The strategy underperformed its benchmark Russell Midcap Growth Index in the quarter. Overall, the effects of stock selection impacted the performance on a relative basis. The strategy gained three of the 11 […]

Yahoo | December 13, 2023

Read More 'SWAV' Stories Here

SWAV Price Returns

1-mo 17.11%
3-mo 47.37%
6-mo 54.90%
1-year 14.85%
3-year 106.42%
5-year 853.62%
YTD 72.65%
2023 -7.32%
2022 15.30%
2021 71.93%
2020 136.16%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!